Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn screening (NBS) programs have traditionally relied on ...

Quantum-Si Incorporated ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced two new manuscripts have ...

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

Interpretation is the discipline through which molecular datasets reveal their significance. As the life sciences enter a new era defined by data richness and technological capacity, interpretive ...

While most research groups rely on organs from cloned, gene-edited pigs created through somatic cell nuclear transfer for pig-to-human transplantation, scientists at the Center for Innovative Medical ...

The Street’s view on Castle Biosciences has shifted, with the consensus analyst price target moving from about US$46.00 to ...

Life sciences company Azenta (NASDAQ:AZTA) reported Q4 CY2025 results , but sales were flat year on year at $148.6 million.

Since 2005, the global count of living mammal species has risen by 25%.

Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2025.

The latest phase of the war is less about maneuvers and operations than alliance politics and shifting allegiances.

Visby Medical, a leading innovator in at-home PCR testing of infectious diseases, has announced a strategic collaboration with Watchmaker Genomics, a supplier of innovative products for molecular anal ...

X-FAB Silicon Foundries SE ( XFABF) Q4 2025 Earnings Call February 5, 2026 12:30 PM EST Welcome to the X-FAB Full Year and Fourth Quarter 2025 Results Conference Call. [Operator Instructions] I will ...